A detailed history of Tradewinds, Llc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tradewinds, Llc. holds 4,948 shares of BMY stock, worth $251,952. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,948
Holding current value
$251,952
% of portfolio
0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $199,157 - $262,194
4,948 New
4,948 $205,000
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $115 - $129
-2 Reduced 0.05%
4,008 $232,000
Q2 2023

Aug 15, 2023

BUY
$63.71 - $70.74 $47,846 - $53,125
751 Added 23.04%
4,010 $256,000
Q1 2023

Apr 06, 2023

BUY
$65.71 - $74.53 $214,148 - $242,893
3,259 New
3,259 $225,000
Q3 2022

Oct 17, 2022

BUY
$0.13 - $76.84 $5 - $2,996
39 Added 1.34%
2,943 $209,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $210,888 - $232,261
2,904 New
2,904 $224,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tradewinds, Llc. Portfolio

Follow Tradewinds, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds, Llc. with notifications on news.